EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Genetically engineered mouse models for hereditary cancer syndromes

Kajal Biswas iD, Altaf Mohammed, Shyam K Sharan, Robert H Shoemaker

Cancer Science · 2023

DOI: 10.1111/cas.15737 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Science, 2023. Verfasst von Kajal Biswas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary, Hereditary Breast and Ovarian Cancer Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in molecular diagnostics have led to improved diagnosis and molecular understanding of hereditary cancers in the clinic. Improving the management, treatment, and potential prevention of cancers in carriers of predisposing mutations requires preclinical experimental models that reflect the key pathogenic features of the specific syndrome associated with the mutations. Numerous genetically engineered mouse (GEM) models of hereditary cancer have been developed. In this review, we describe the models of Lynch syndrome and hereditary breast and ovarian cancer syndrome, the two most common hereditary cancer predisposition syndromes. We focus on Lynch syndrome models as illustrative of the potential for using mouse models to devise improved approaches to prevention of cancer in a high‐risk population. GEM models are an invaluable tool for hereditary cancer models. Here, we review GEM models for some hereditary cancers and their potential use in cancer prevention studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal Neoplasms, Hereditary NonpolyposisNeoplastic Syndromes, HereditaryHereditary Breast and Ovarian Cancer SyndromeHumansFemaleAnimalsMiceGenetic Predisposition to DiseaseMutation

Stichwörter der Autor:innen

cancer geneticsdisease modelgenetically engineered micehereditary cancersmouse models

Autor:innen und Institutionen

  • Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland, USA.
  • Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland, USA.

ORCID-Profile: Kajal Biswas

Zitieren

APA

Biswas, K., Mohammed, A., Sharan, S. K., & Shoemaker, R. H. (2023). Genetically engineered mouse models for hereditary cancer syndromes. Cancer Science. https://doi.org/10.1111/cas.15737

Vancouver

Biswas K, Mohammed A, Sharan SK, Shoemaker RH. Genetically engineered mouse models for hereditary cancer syndromes. Cancer Science. 2023. doi:10.1111/cas.15737

BibTeX
@article{Biswas2023,
  author = {Biswas, Kajal and Mohammed, Altaf and Sharan, Shyam K and Shoemaker, Robert H},
  title = {Genetically engineered mouse models for hereditary cancer syndromes},
  journal = {Cancer Science},
  year = {2023},
  doi = {10.1111/cas.15737}
}
Kostenlos starten →